Injection Studies

CenExel supports advanced clinical research evaluating injectable therapies across a broad range of therapeutic areas. Our experienced investigators and dedicated research sites help sponsors assess safety, tolerability, pharmacokinetics, and efficacy while ensuring high-quality data collection and patient care throughout every stage of development.

Studies Conducted
Acute & post-surgical pain focus
0 +
Trial Participants
Enrolled in acute pain studies
0 +
Active Sites
Specialized research locations
0
Overview

Leading Injectable Therapy Clinical Research

CenExel provides comprehensive support for injectable drug development, from first-in-human studies through late-phase clinical trials. Our experienced teams are equipped to manage complex protocols involving intravenous (IV), subcutaneous (SC), intramuscular (IM), and biologic therapies.

With a strong focus on patient safety, protocol compliance, and operational excellence, we help sponsors accelerate development timelines while generating reliable clinical data. Our integrated network offers access to diverse patient populations and specialized clinical expertise across multiple therapeutic areas.

Conditions Covered

Injectable Therapies We Research

Our research sites support a wide range of injectable therapies and treatment modalities, including:

Biologic Therapies

Monoclonal Antibodies

Vaccines

Gene & Cell Therapies

Autoimmune Disease Treatments

Oncology Injectables

Metabolic & Endocrine Therapies

Neurology Injectables

Pain Management Injections

Specialty Pharmaceutical Products

Our Approach

Why Sponsors Choose CenExel for Injection Studies

Our injection expertise goes beyond patient enrollment — we provide scientific guidance, efficient study execution, and dependable results from first dose to final outcome.

01

Specialized Dosing Expertise

Experienced teams trained in intravenous, subcutaneous, intramuscular, and biologic administration procedures.

02

Advanced Clinical Infrastructure

Dedicated facilities designed to support injectable therapies requiring close monitoring and specialized equipment.

03

Strong Safety Oversight

Comprehensive safety assessment and adverse event monitoring throughout study participation.

04

Reliable Patient Recruitment

Access to diverse patient populations and proven enrollment strategies that support study timelines.

Phase Coverage

Supported Trial Phases

We support injectable therapy clinical trials across all stages of development:

Active across all phases

Phase I

Phase II

Phase III

Phase IV

Injection Research Excellence

CenExel's injection research teams bring together experienced investigators, clinical pharmacologists, research nurses, and operational specialists to support complex injectable therapy studies.

Active Sites

15 Sites

CenExel Gaithersburg
CenExel Garden Grove
CenExel Atlanta
CenExel Marlton
CenExel Hollywood